Articles

Australia's medicines regulator, the Therapeutic Goods Administration, has today issued precautionary advice to doctors not to give patients a second dose of the vaccine Pneumovax 23 pending completion of an investigation into an increased rate of adverse events in people receiving the vaccine for the second time.

TGA is conducting a panel-led review to explore ways to improve transparency and public engagement in its regulatory work.

The Therapeutic Goods Administration (TGA) officially launched a new organisational structure on 1 July 2010.

Therapeutic Goods Order No. 1 of 2010.

The Therapeutic Goods Administration (TGA) has approved an extension to the shelf life for Tamiflu (oseltamivir) from five to seven years, when stored below 25°C. This extension is effective from 1 May 2009.

This Order may be cited as the Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2004.

Listing notice - tocotrienols complex - palm

Listing notice - lactoferrin - bovine, colloidal anhydrous silica or silicon dioxide, glucosamine sulfate-potassium chloride complex or glucosamine sulfatesodium chloride complex, R,S- or R-alpha lipoic acid, levocarnitine, acctyllevocarnitine hydrochloride, propionyllcvocarnitine hydrochloride, levocarnitine hydrochloride, levocarnitine tartrate, levocarnitine fumarate or levocarnitine magnesium citrate, bromclain, lecithin, soy -soy phosphatidylserine-enriched

Listing notice - colloidal anhydrous silica or silicon dioxide

Listing notice - hydroxycitric acid, potassium hydroxycitrate, sodium hydroxycitrate, calcium hydroxycitrate, squalene, fresh leaf extract of alfalfa (Medicago sativa), Kunzea ambigua essential oil, dried green lipped mussel (Perna canaliculus)

Listing notice - sodium selenite, selenomethionine, selenocysteine, high selenium yeast, Bifidobacterium longum strain BB536, beta-hydroxy-beta-methylbutyric acid, calcium beta-hvdroxy-beta-methylbutyrate, sodium beta-hydroxy-beta-methylbutyrate

Listing notice - ubidecarenone, honey